Iyer D, Venkatraman J, Tanguy E, Vitale N, Mahapatra N
Cell Mol Life Sci. 2023; 80(9):271.
PMID: 37642733
PMC: 11072126.
DOI: 10.1007/s00018-023-04908-3.
Witeck C, Schmitz A, Oliveira J, Porporatti A, De Luca Canto G, de Souza Pires M
J Pediatr (Rio J). 2021; 98(1):4-14.
PMID: 33964214
PMC: 9432115.
DOI: 10.1016/j.jped.2021.03.003.
Strebinger G, Muller E, Feldman A, Aigner E
Hepat Med. 2019; 11:79-88.
PMID: 31213932
PMC: 6536894.
DOI: 10.2147/HMER.S201630.
Aguisanda F, Thorne N, Zheng W
Curr Chem Genom Transl Med. 2017; 11:1-18.
PMID: 28401034
PMC: 5362971.
DOI: 10.2174/2213988501711010001.
Ortiz-Miranda S, Ji R, Jurczyk A, Aryee K, Mo S, Fletcher T
Am J Physiol Gastrointest Liver Physiol. 2016; 311(5):G903-G919.
PMID: 27659423
PMC: 5130545.
DOI: 10.1152/ajpgi.00313.2015.
Clinical Features of Lysosomal Acid Lipase Deficiency.
Burton B, Deegan P, Enns G, Guardamagna O, Horslen S, Hovingh G
J Pediatr Gastroenterol Nutr. 2015; 61(6):619-25.
PMID: 26252914
PMC: 4645959.
DOI: 10.1097/MPG.0000000000000935.
Hepatocyte-Specific Expression of Human Lysosome Acid Lipase Corrects Liver Inflammation and Tumor Metastasis in lal(-/-) Mice.
Du H, Zhao T, Ding X, Yan C
Am J Pathol. 2015; 185(9):2379-89.
PMID: 26212911
PMC: 4597280.
DOI: 10.1016/j.ajpath.2015.05.021.
Novel LIPA mutations in Mexican siblings with lysosomal acid lipase deficiency.
Santillan-Hernandez Y, Almanza-Miranda E, Xin W, Goss K, Vera-Loaiza A, Gorraez-de la Mora M
World J Gastroenterol. 2015; 21(3):1001-8.
PMID: 25624737
PMC: 4299316.
DOI: 10.3748/wjg.v21.i3.1001.
Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency.
Valayannopoulos V, Malinova V, Honzik T, Balwani M, Breen C, Deegan P
J Hepatol. 2014; 61(5):1135-42.
PMID: 24993530
PMC: 4203712.
DOI: 10.1016/j.jhep.2014.06.022.
Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.
Thelwall P, Smith F, Leavitt M, Canty D, Hu W, Hollingsworth K
J Hepatol. 2013; 59(3):543-9.
PMID: 23624251
PMC: 3749380.
DOI: 10.1016/j.jhep.2013.04.016.
Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease.
Balwani M, Breen C, Enns G, Deegan P, Honzik T, Jones S
Hepatology. 2013; 58(3):950-7.
PMID: 23348766
PMC: 3728169.
DOI: 10.1002/hep.26289.
Genomics and proteomics of vertebrate cholesterol ester lipase (LIPA) and cholesterol 25-hydroxylase (CH25H).
Holmes R, VandeBerg J, Cox L
3 Biotech. 2012; 1(2):99-109.
PMID: 22582164
PMC: 3324826.
DOI: 10.1007/s13205-011-0013-9.
Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice.
Du H, Cameron T, Garger S, Pogue G, Hamm L, White E
J Lipid Res. 2008; 49(8):1646-57.
PMID: 18413899
PMC: 2444013.
DOI: 10.1194/jlr.M700482-JLR200.
The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy.
Du H, Levine M, Ganesa C, Witte D, Cole E, Grabowski G
Am J Hum Genet. 2005; 77(6):1061-74.
PMID: 16380916
PMC: 1285163.
DOI: 10.1086/498652.
Acid lipase cross-reacting material in Wolman disease and cholesterol ester storage disease.
Burton B, Reed S
Am J Hum Genet. 1981; 33(2):203-8.
PMID: 6782865
PMC: 1684950.
Cholesteryl ester storage disease and Wolman disease: phenotypic variants of lysosomal acid cholesteryl ester hydrolase deficiency.
Hoeg J, Demosky Jr S, Pescovitz O, BREWER Jr H
Am J Hum Genet. 1984; 36(6):1190-203.
PMID: 6097111
PMC: 1684644.
Plasma lipids and lipoproteins of a patient with cholesteryl ester storage disease.
Kostner G, HADORN B, Roscher A, Zechner R
J Inherit Metab Dis. 1985; 8(1):9-12.
PMID: 3921762
DOI: 10.1007/BF01805475.
Long-term treatment of a homozygous cholesteryl ester storage disease with combined cholestyramine and lovastatin.
Yokoyama S, McCOY E
J Inherit Metab Dis. 1992; 15(2):291-2.
PMID: 1528002
DOI: 10.1007/BF01799650.